Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OmniAb (OABI) Assets (2021 - 2025)

OmniAb has reported Assets over the past 5 years, most recently at $300.9 million for Q4 2025.

  • Quarterly Assets fell 7.57% to $300.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $300.9 million through Dec 2025, down 7.57% year-over-year, with the annual reading at $300.9 million for FY2025, 7.57% down from the prior year.
  • Assets was $300.9 million for Q4 2025 at OmniAb, down from $309.7 million in the prior quarter.
  • Over five years, Assets peaked at $421.2 million in Q4 2022 and troughed at $633415.0 in Q2 2021.
  • The 5-year median for Assets is $309.7 million (2025), against an average of $306.3 million.
  • Year-over-year, Assets soared 37283.13% in 2022 and then dropped 16.77% in 2024.
  • A 5-year view of Assets shows it stood at $304.5 million in 2021, then surged by 38.34% to $421.2 million in 2022, then dropped by 10.92% to $375.2 million in 2023, then decreased by 13.24% to $325.6 million in 2024, then decreased by 7.57% to $300.9 million in 2025.
  • Per Business Quant, the three most recent readings for OABI's Assets are $300.9 million (Q4 2025), $309.7 million (Q3 2025), and $295.7 million (Q2 2025).